Welcure Drugs and Pharmaceuticals last traded at ₹0.20 (2026-10-13). Over the past month the stock moved -9.1%, three months the stock moved -31.0%, year the stock moved -63.6%. Its closing range over 52 weeks is ₹0.20 – ₹0.74, with the latest close 73.0% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1992, Welcure Drugs and Pharmaceuticals Ltd is in the business of pharmaceutical and healthcare.[1]
Business Overview:[1] WDPL is engaged in the manufacture and trade of a wide range of healthcare formulations.
In the latest quarter (Mar 2026), Welcure Drugs and Pharmaceuticals reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-50.00 crore (-1766.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -50.00 | – | -50.00 | -0.40 |
| Dec 2025 | 0.00 | 0.00 | – | 1.00 | 0.01 |
| Sep 2025 | 66.00 | 11.00 | 17.00 | 8.00 | 0.07 |
| Jun 2025 | 300.00 | 31.00 | 10.00 | 23.00 | 0.19 |
| Mar 2025 | 21.00 | 1.00 | 3.00 | 3.00 | 0.02 |
| Dec 2024 | 1.00 | 0.00 | 10.00 | 0.00 | 0.00 |
| Sep 2024 | 25.00 | 2.00 | 7.00 | 2.00 | 0.01 |
| Jun 2024 | 0.00 | 0.00 | – | 0.00 | -0.02 |
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | +164.0% | -100.0% | -100.0% |
| Operating profit growth | – | – | – | – | – | +450.0% | – | -5100.0% |
| Net profit growth | – | – | – | – | – | +300.0% | – | -1766.7% |
| EPS growth | – | – | – | – | – | +600.0% | – | -2100.0% |
| OPM % | – | 7.0% | 10.0% | 3.0% | 10.0% | 17.0% | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Welcure Drugs and Pharmaceuticals reported sales of ₹366.00 crore (+1390.8%) and net profit of ₹-5.00 crore (-330.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 366.00 | -7.00 | -2.00 | -5.00 | -0.04 |
| Mar 2025 | 24.55 | 0.88 | 3.58 | 2.17 | 0.19 |
| Mar 2024 | 0.00 | -0.23 | – | -0.17 | -0.13 |
| Mar 2023 | 0.00 | -0.14 | – | 0.10 | 0.07 |
| Mar 2022 | 0.11 | 0.02 | 18.18 | 0.02 | 0.01 |
| Mar 2021 | 0.13 | 0.06 | 46.15 | 0.06 | 0.04 |
| Mar 2020 | 0.08 | -0.01 | -12.50 | -0.01 | -0.01 |
| Mar 2019 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +60.0% | +0.0% | +62.5% | -15.4% | -100.0% | – | – | +1390.8% |
| Operating profit growth | – | – | – | -66.7% | -800.0% | – | – | -895.5% |
| Net profit growth | – | – | – | -66.7% | +400.0% | -270.0% | – | -330.4% |
| EPS growth | – | – | – | -75.0% | +600.0% | -285.7% | – | -121.1% |
| OPM % | 0.0% | -12.5% | 46.2% | 18.2% | – | – | 3.6% | -2.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Welcure Drugs and Pharmaceuticals.
Get Free AI Stock Analysis FREE →No recent news available for Welcure Drugs and Pharmaceuticals.
Welcure Drugs and Pharmaceuticals shares were last quoted at ₹0.20 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Welcure Drugs and Pharmaceuticals has a price-to-earnings (P/E) ratio of -1.57 and a price-to-book (P/B) ratio of 0.29. The industry P/E is 53.33.
The 52-week high of Welcure Drugs and Pharmaceuticals is ₹0.81 and the 52-week low is ₹0.19.
The market capitalisation of Welcure Drugs and Pharmaceuticals is about ₹27.19 crore.
In the latest quarter (Mar 2026), Welcure Drugs and Pharmaceuticals reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-50.00 crore (-1766.7%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Welcure Drugs and Pharmaceuticals has a 3-year ROE of -2.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Welcure Drugs and Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.